CHARLOTTE, N.C. (TheStreet) -- I like growth stocks and so should you. The object of managing your own portfolio is to whittle down the 12,000 stocks you might invest in and find the dozen you need for your portfolio that fits all of your criteria and has the best chance to beat the market.I think the medical appliance and equipment company Cyberonics ( CYBX) is that kind of stock and I'll walk you through the reasons why. First I like to see price momentum. If the market isn't responding to a stock, why should you? In the past month the stock has been up almost 8% as you can see in this hourly trading chart provided by
Revenue projected to increase by 1.90% this year and 3.10% next year Earning estimated to be up 5.80% this year and 5.50% next year TheStreet readers rate the stock A- Baxter International: Revenue projected to increase by 2.50% this year and 4.50% next year Earnings estimated to be up 5.10% this year and 8.20% next year TheStreet readers rate the stock A- Covidien: Revenue projected to be up 2.80% this year and 4.80% next year Earnings estimated to increase by 8.30% this year and 7.70% next year The readers of TheStreet rate the stock A- Summary: Cyberonics has double-digit projections for both sales and earnings and a B+ balance sheet. The recent price momentum shows others are finding this stock. The readers of TheStreet rate all four stocks A- but CYBX has superior growth projections. To make sure you are not too late to the party I'd advise you to watch the 100-day moving average and the lower 14-day turtle chart if a weakness is signalled: At the time of publication the author had no shares of Cyberonics although it is on his watch list.